Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)

眼睛生长、正视眼和感光器间视黄醇结合蛋白 (IRBP)

基本信息

  • 批准号:
    8662781
  • 负责人:
  • 金额:
    $ 38.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): IRBP has long been assumed to function in the visual cycle because of its retinoid binding properties and its localization to the interphotoreceptor space. However, IRBP mRNA and protein expression precede opsin expression and the last mitosis of photoreceptor precursor cells, that is, well before IRBP would function in the visual cycle. From this anomaly we hypothesize that early IRBP gene expression is important in development. In testing this hypothesis, we unexpectedly find that IRBP knockout (KO) mice develop high myopia, with aberrant eye growth starting after P7 and before P10, well before eyes open. This implies a role for IRBP in controlling eye growth even without vision-based signaling. Additionally, we find that IRBP KO mice lack correct developmental pruning and movement of retinal inner nuclear layer (INL) cells, including inner rods, suggesting that IRBP plays a role in retinal cell fate. Finally, we find that IRBP deficiency results in rod photoreceptr degeneration. We propose to test whether the development of myopia results in this degeneration, or whether the degeneration separately results from IRBP deficiency. A simple and organized set of focused experiments that test the hypotheses with sensible workload are proposed in two aims. These are: Aim 1. To test the predictions that myopia can be attributed uniquely to the absence of the IRBP protein in the interphotoreceptor space (IPS) of the KO mouse in a critical time window of P7-P10, and whether myopia can be prevented by restoring IRBP to its correct location in the IPS in the same critical time window. Aim 2. To test whether the myopia observed in the absence of IRBP is required for the subsequent retinal degeneration (RD) or whether the absence of IRBP, separate from myopia etiology, is responsible for the RD.
描述(由申请人提供):IRBP长期以来被认为在视觉周期中起作用,因为其类维生素A结合特性及其定位于感光器间空间。然而,IRBP mRNA和蛋白质的表达先于视蛋白的表达和感光前体细胞的最后一次有丝分裂,也就是说,早于IRBP在视觉周期中发挥作用。从这个异常,我们推测,早期IRBP基因表达是重要的发展。在测试这一假设时,我们意外地发现IRBP敲除(KO)小鼠发生高度近视,在P7之后和P10之前,在眼睛睁开之前,眼睛开始异常生长。这意味着IRBP在控制眼睛生长中的作用,即使没有基于视觉的信号。此外,我们发现IRBP KO小鼠缺乏正确的发育修剪和视网膜内核层(INL)细胞(包括内杆)的运动,表明IRBP在视网膜细胞命运中起作用。最后,我们发现IRBP缺乏导致视杆细胞光感受器变性。我们建议测试近视的发展是否导致这种变性,或者是否单独的变性是由IRBP缺乏引起的。一个简单而有组织的集中实验,测试与合理的工作量的假设提出了两个目标。目标1:目标1。检测在P7-P10的关键时间窗内,KO小鼠的光感受器间间隙(IPS)中IRBP蛋白的缺失可唯一归因于近视的预测,以及是否可通过在相同的关键时间窗内将IRBP恢复到其在IPS中的正确位置来预防近视。目标二。测试在不存在IRBP的情况下观察到的近视是否是后续视网膜变性(RD)所必需的,或者与近视病因无关的IRBP的缺乏是否是RD的原因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John M Nickerson其他文献

Development of an Improved Tracheal Explant Bioassay for the Detection of the Ciliary Dyskinesia Factor in Cystic Fibrosis Serum
一种用于检测囊性纤维化血清中纤毛运动障碍因子的改良气管外植体生物测定法的开发
  • DOI:
    10.1203/00006450-197901000-00007
  • 发表时间:
    1979-01-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Michael G Gabridge;Marlene J Bright;C Coe Agee;John M Nickerson;Nanine S Henderson
  • 通讯作者:
    Nanine S Henderson

John M Nickerson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John M Nickerson', 18)}}的其他基金

Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)
眼睛生长、正视眼和感光器间视黄醇结合蛋白 (IRBP)
  • 批准号:
    8439134
  • 财政年份:
    2013
  • 资助金额:
    $ 38.22万
  • 项目类别:
Topical delivery of nanoencapsulated plasmid DNA to posterior ocular targets
将纳米封装的质粒 DNA 局部递送至眼后部目标
  • 批准号:
    8252690
  • 财政年份:
    2012
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    8372573
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    7034078
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    8866405
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    7599590
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    8689037
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    7408017
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    8519457
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:
Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
  • 批准号:
    7198012
  • 财政年份:
    2006
  • 资助金额:
    $ 38.22万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 38.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了